Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L George

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Statistics in Biopharmaceutical Research|March 12, 2010
Flexible Phase I Clinical Trials: Allowing for Nonbinary Toxicity Response and Removal of Other Common LimitationsRichard F Potthoff, Stephen L George
Journal of Biopharmaceutical Statistics|April 23, 2009
Between-arm comparisons in randomized Phase II trialsSin-Ho Jung, Stephen L George
Statistics in Medicine|May 4, 2004
Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?Susan S Ellenberg, Stephen L George
Biostatistics (Oxford, England)|June 23, 2012
ROC curve estimation under test-result-dependent samplingXiaofei Wang, Junling Ma, Stephen L George
Statistics in Biopharmaceutical Research|May 31, 2016
A Multi-state Model for Designing Clinical Trials for Testing Overall Survival Allowing for Crossover after ProgressionFang Xia, Stephen L George, Xiaofei Wang
Statistics in Biopharmaceutical Research|August 4, 2025
Assessment of treatment effect heterogeneity for multiregional randomized clinical trialsHaotian Zhuang, Xiaofei Wang, Stephen L George
Journal of Biopharmaceutical Statistics|November 11, 2005
Sample size calculation for simulation-based multiple-testing proceduresHeejung Bang, Sin-Ho Jung, Stephen L George
Statistics in Medicine|September 29, 2005
A multiple testing procedure to associate gene expression levels with survivalSin-Ho Jung, Kouros Owzar, Stephen L George
Statistics in Medicine|February 24, 2011
Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpointStefan Michiels, Richard F Potthoff, Stephen L George
Controlled Clinical Trials|February 26, 2004
Data monitoring and large apparent treatment effectsEdward L Korn, Boris Freidlin, Stephen L George
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Statistics in Biopharmaceutical Research|March 12, 2010
Flexible Phase I Clinical Trials: Allowing for Nonbinary Toxicity Response and Removal of Other Common LimitationsRichard F Potthoff, Stephen L George
Journal of Biopharmaceutical Statistics|April 23, 2009
Between-arm comparisons in randomized Phase II trialsSin-Ho Jung, Stephen L George
Statistics in Medicine|May 4, 2004
Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?Susan S Ellenberg, Stephen L George
Biostatistics (Oxford, England)|June 23, 2012
ROC curve estimation under test-result-dependent samplingXiaofei Wang, Junling Ma, Stephen L George
Statistics in Biopharmaceutical Research|May 31, 2016
A Multi-state Model for Designing Clinical Trials for Testing Overall Survival Allowing for Crossover after ProgressionFang Xia, Stephen L George, Xiaofei Wang
Statistics in Biopharmaceutical Research|August 4, 2025
Assessment of treatment effect heterogeneity for multiregional randomized clinical trialsHaotian Zhuang, Xiaofei Wang, Stephen L George
Journal of Biopharmaceutical Statistics|November 11, 2005
Sample size calculation for simulation-based multiple-testing proceduresHeejung Bang, Sin-Ho Jung, Stephen L George
Statistics in Medicine|September 29, 2005
A multiple testing procedure to associate gene expression levels with survivalSin-Ho Jung, Kouros Owzar, Stephen L George
Statistics in Medicine|February 24, 2011
Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpointStefan Michiels, Richard F Potthoff, Stephen L George
Controlled Clinical Trials|February 26, 2004
Data monitoring and large apparent treatment effectsEdward L Korn, Boris Freidlin, Stephen L George
Pageof 6